These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24198926)

  • 1. Does intravenous immunoglobulin therapy prolong immunodeficiency in transient hypogammaglobulinemia of infancy?
    Memmedova L; Azarsiz E; Edeer Karaca N; Aksu G; Kutukculer N
    Pediatr Rep; 2013; 5(3):e14. PubMed ID: 24198926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient hypogammaglobulinemia of infancy: intravenous immunoglobulin as first line therapy.
    Duse M; Iacobini M; Leonardi L; Smacchia P; Antonetti L; Giancane G
    Int J Immunopathol Pharmacol; 2010; 23(1):349-53. PubMed ID: 20378022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
    Ameratunga R; Ahn Y; Steele R; Woon ST
    Front Immunol; 2019; 10():1541. PubMed ID: 31379811
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.
    Nettagul R; Visitsunthorn N; Vichyanond P
    J Med Assoc Thai; 2003 Jul; 86(7):686-92. PubMed ID: 12948264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hypogammaglobulinemia and unclassified hypogammaglobulinemia: 'similarities and differences'.
    Keles S; Artac H; Kara R; Gokturk B; Ozen A; Reisli I
    Pediatr Allergy Immunol; 2010 Aug; 21(5):843-51. PubMed ID: 20609138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency.
    Genel F; Kutukculer N
    Curr Ther Res Clin Exp; 2003 Sep; 64(8):600-15. PubMed ID: 24944407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network.
    Moschese V; Graziani S; Avanzini MA; Carsetti R; Marconi M; La Rocca M; Chini L; Pignata C; Soresina AR; Consolini R; Bossi G; Trizzino A; Martino S; Cardinale F; Bertolini P; Marseglia GL; Zecca M; Di Cesare S; Quinti I; Rondelli R; Pietrogrande MC; Rossi P; Plebani A
    Int J Immunopathol Pharmacol; 2008; 21(2):343-52. PubMed ID: 18547478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
    Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
    Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient hypogammaglobulinemia of infancy presenting as Staphylococcus aureus sepsis with deep neck infection.
    Hsueh KC; Chiu HH; Lin HC; Hsu CH; Tsai FJ
    J Microbiol Immunol Infect; 2005 Apr; 38(2):141-4. PubMed ID: 15843860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocyte subsets and outcomes in patients with an initial diagnosis of transient hypogammaglobulinemia of infancy.
    Eroglu FK; Aerts Kaya F; Cagdas D; Özgür TT; Yılmaz T; Tezcan İ; Sanal Ö
    Scand J Immunol; 2018 Oct; 88(4):e12709. PubMed ID: 30152873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient hypogammaglobulinemia of infancy: predictive factors for late recovery.
    Sütçü M; Aktürk H; Salman N; Özçeker D; Gülümser-Şişko S; Acar M; Somer A
    Turk J Pediatr; 2015; 57(6):592-598. PubMed ID: 27735798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New laboratory findings in Turkish patients with transient hypogammaglobulinemia of infancy.
    Karaca NE; Aksu G; Gulez N; Yildiz B; Azarsiz E; Kutukculer N
    Iran J Allergy Asthma Immunol; 2010 Dec; 9(4):237-43. PubMed ID: 21131704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
    Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma.
    Chapel HM; Lee M; Hargreaves R; Pamphilon DH; Prentice AG
    Lancet; 1994 Apr; 343(8905):1059-63. PubMed ID: 7909099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era.
    Baek DW; Song GY; Lee HS; Do YR; Lee JH; Yhim HY; Moon JH; Yang DH
    Front Oncol; 2024; 14():1380492. PubMed ID: 38715775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
    Sarmiento E; Fernàndez-Yáñez J; Muñoz P; Palomo J; Rodríguez-Molina JJ; Bermejo J; Catalan P; Bouza E; Fernández-Cruz E; Carbone J
    Int Immunopharmacol; 2005 Jan; 5(1):97-101. PubMed ID: 15589466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.
    Casulo C; Maragulia J; Zelenetz AD
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):106-11. PubMed ID: 23276889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
    Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
    J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.